BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Chi-Med Initiates Fruquintinib U.S. Clinical Trials

  Chi-Med has initiated the United States Phase I bridging clinical trial of fruquintinib.

  December 15, 2017

   · 

  5 min read
• Biotech Beach

  Trovagene Prices $4.5M Public Offering

  TrovaGene today announced the pricing of a public offering of 15,000,000 shares of its common stock and common warrants to purchase up to an aggregate of 15,000,000 shares of common stock.

  December 15, 2017

   · 

  4 min read
• Drug Development

  H3 Biomedicine’s Preclinical Data Highlighting Novel Discovery Research in Hepatocellular Carcinoma Published in December Issue of Cancer Research

  The data were recently presented at the International Liver Cancer Association annual meeting held in Seoul, Republic of Korea.

  December 15, 2017

   · 

  3 min read
• Business

  China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province

  The Company announced the receipt of approval to build one new plasma collection station in Ju County and one branch collection center in Feicheng County, respectively, in January 2017.

  December 15, 2017

   · 

  4 min read
• Biotech Beach

  CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

  ViaCyte today announced that the CIRM approved a grant of $1.4M to support the initial development of immune-evasive pluripotent stem cell lines.

  December 15, 2017

   · 

  4 min read
• Genetown

  Verastem Announces Pricing of Public Offering of Common Stock

  Verastem announced the pricing of its previously announced underwritten public offering of approximately $25 million of shares of its common stock.

  December 15, 2017

   · 

  3 min read
• Business

  Dr. Sally Ann Forsyth Appointed CEO of Stevenage Bioscience Catalyst

  With scientific and financial expertise and as an open innovation practitioner, Forsyth will lead SBC through its next phase of expansion.

  December 15, 2017

   · 

  2 min read
• Business

  Professor Ruth Roberts of Alderley Park’s Apconix Receives International Award for Drug and Chemical Safety Work

  Professor Ruth Roberts - co-founder and director of nonclinical safety company, ApconiX based at Alderley Park, Cheshire - is the first non-US-based scientist to receive a prestigious international award for professionals specialising in drug and chemical safety.

  December 15, 2017

   · 

  2 min read
• Policy

  Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications

  This will be the eighth IND program developed by Athenex.

  December 15, 2017

   · 

  5 min read
• Business

  Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-Linked Chronic Granulomatous Disease

  X-linked CGD is a primary immune deficiency resulting from a mutation on the X-chromosome and affecting mainly boys.

  December 15, 2017

   · 

  3 min read